SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 197 filers reported holding SANGAMO THERAPEUTICS INC in Q4 2018. The put-call ratio across all filers is 1.06 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $111,000 | -24.0% | 17,446 | 0.0% | 0.00% | 0.0% |
| Q4 2019 | $146,000 | -7.6% | 17,446 | 0.0% | 0.00% | -33.3% |
| Q3 2019 | $158,000 | -16.0% | 17,446 | 0.0% | 0.00% | -25.0% |
| Q2 2019 | $188,000 | +13.3% | 17,446 | 0.0% | 0.00% | 0.0% |
| Q1 2019 | $166,000 | -17.0% | 17,446 | 0.0% | 0.00% | -20.0% |
| Q4 2018 | $200,000 | -32.4% | 17,446 | 0.0% | 0.01% | +25.0% |
| Q3 2018 | $296,000 | +19.4% | 17,446 | 0.0% | 0.00% | -20.0% |
| Q2 2018 | $248,000 | +6.4% | 17,446 | +42.5% | 0.01% | 0.0% |
| Q1 2018 | $233,000 | +33.1% | 12,246 | +15.0% | 0.01% | +150.0% |
| Q4 2017 | $175,000 | – | 10,646 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FIC CAPITAL INC | 875,284 | $2,670,000 | 1.34% |
| NEXTHERA CAPITAL LP | 503,000 | $1,534,000 | 0.90% |
| Opaleye Management Inc. | 400,000 | $1,220,000 | 0.72% |
| WASATCH ADVISORS LP | 7,256,260 | $22,132,000 | 0.33% |
| Cormorant Asset Management, LP | 650,000 | $1,983,000 | 0.27% |
| Sicart Associates LLC | 101,950 | $311,000 | 0.22% |
| Baker Brothers Advisors | 4,055,876 | $12,370,000 | 0.12% |
| Leisure Capital Management | 43,008 | $131,000 | 0.12% |
| Piermont Capital Management Inc. | 165,569 | $505,000 | 0.12% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 837,963 | $2,556,000 | 0.10% |